• Home
  • Market
  • KEC International’s Share Price Recovers Following ₹1,236 Crore Order Win: Key Insights Inside
KEC International's Share Price Recovers Following ₹1,236 Crore Order Win: Key Insights Inside

KEC International’s Share Price Recovers Following ₹1,236 Crore Order Win: Key Insights Inside

KEC International’s stock experienced a dip of nearly 3% during early trading on the Bombay Stock Exchange (BSE) on Tuesday, April 1. However, the engineering and construction firm managed to recover some losses in a challenging market following the announcement of a significant order win valued at ₹1,236 crore. Opening at ₹780.15, the shares fell to ₹762.15 before recovering to ₹773.55 by 1:15 PM, representing a smaller decline of 1.15%.

KEC International’s Order Win Breakdown

On April 1, KEC International revealed through an exchange filing that it had successfully secured new orders totaling ₹1,236 crore across various sectors, including transmission and distribution (T&D), civil engineering, transportation, and cables.

  • Transmission and Distribution: The company clinched contracts for projects in India and the Middle East. In the UAE and Kuwait, it won orders related to transmission lines and substations. Meanwhile, in India, orders for substations were awarded by a private TBCB player.
  • Civil Engineering: KEC’s civil division landed a significant contract for a residential project from a prominent developer in western India.
  • Transportation: The firm’s transportation division secured a crucial order in the Train Collision Avoidance System (TCAS) segment, part of the innovative ‘Kavach’ initiative in India.
  • Cables: The cables division received orders for various types of cables for both domestic and international supply.

Vimal Kejriwal, Managing Director and CEO of KEC International, expressed enthusiasm about the new contracts, particularly highlighting the substation orders in both domestic and international markets. "The order wins in the UAE have notably enhanced our portfolio in the Middle East substation market," he stated. He further added, “Our civil division continues to broaden its horizons with the inclusion of a well-known real estate developer. As a result, our total order intake for FY25 has reached an impressive ₹24,600 crore, reflecting a remarkable growth of 36% compared to the previous year.”

See also  Volatile Fund Inflows in Mutual Funds Expected in the Near Term: Key Insights from Recent Report

Stock Performance Insights

Over the last year, KEC International’s share price has seen a moderate increase of 13%. Notably, the stock reached a 52-week low of ₹648.45 on March 3 and peaked at ₹1,312 on December 4 of the previous year.

For more insights into market trends and stock performance, stay tuned for the latest updates on KEC International and other key players in the industry.

Related Post

Zerodha CEO Nithin Kamath Urges Investors: 'Pause Your Trading During Challenging Times for Better Results'
Zerodha CEO Nithin Kamath Urges Investors: ‘Pause Your Trading During Challenging Times for Better Results’
ByAbhinandanApr 9, 2025

Nithin Kamath, co-founder and CEO of Zerodha, advises investors to pause trading amid rising volatility…

Market Update: S&P 500, Dow Jones, and Nasdaq Rise as Trade War Eases; Apple and Nvidia Surge 2.5%
Market Update: S&P 500, Dow Jones, and Nasdaq Rise as Trade War Eases; Apple and Nvidia Surge 2.5%
ByAbhinandanApr 9, 2025

On April 9, U.S. stock markets saw a slight increase, driven by gains in the…

Global Market Meltdown: Dow Futures Plunge 2% as China Imposes New Tariffs on US, UK’s FTSE Plummets 4%
Global Market Meltdown: Dow Futures Plunge 2% as China Imposes New Tariffs on US, UK’s FTSE Plummets 4%
ByAbhinandanApr 9, 2025

Global stock markets plunged on April 9, with Dow Jones Futures dropping over 2% ahead…

Navigating US Tariffs: How Indian Pharma Giants like Dr. Reddy’s and Sun Pharma Can Overcome Trump's Trade Challenges
Navigating US Tariffs: How Indian Pharma Giants like Dr. Reddy’s and Sun Pharma Can Overcome Trump’s Trade Challenges
ByAbhinandanApr 9, 2025

President Donald Trump plans to impose tariffs on pharmaceutical imports, primarily targeting countries like Ireland…

Leave a Reply

Your email address will not be published. Required fields are marked *

JOIN US

Get Newsletter

Subscribe our newsletter to get the best stories into your inbox!